Scandinavian ChemoTech AB develops and markets medical technology products for tumor treatment in humans and animals. Its proprietary Tumour Specific Electroporation (TSE) platform and IQwave system use targeted electric pulses to enhance the efficacy of low-dose chemotherapy while preserving healthy tissue.
Subscribe to see Scandinavian ChemoTech B’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Scandinavian ChemoTech B is a health care company headquartered in Sweden. Xcout tracks 6 named people at Scandinavian ChemoTech B, including Robin Sukhia (Chairman of the Board of Directors).
A few of Scandinavian ChemoTech B's closest competitors — see the full list of competitors and alternatives →
Neem's Hill AB, formerly known as Scandinavian ChemoTech AB, is a Swedish medical technology company based in Lund. The company develops and markets patented treatment alternatives and technology platforms based on electrochemotherapy for cancer treatment in humans and animals.
SciBase Holding AB is a Swedish medical-technology company whose primary product, Nevisense, uses electrical impedance spectroscopy to support the assessment of suspicious skin lesions, including melanoma. It serves dermatologists and other healthcare professionals involved in skin-cancer detection and diagnosis.
ChemoMetec A/S is a Danish life-science company that develops and sells automated cell-counting and cell-analysis instruments, consumables, and software, including the NucleoCounter product line. Its customers include pharmaceutical and biotechnology companies, research institutions, and cell-therapy and other biological manufacturing laboratories.
Scandinavian Medical Solutions is a Danish company that trades, refurbishes, and installs used medical imaging equipment, including MRI and CT scanners. It serves hospitals, diagnostic clinics, and other healthcare providers internationally.
NanoEcho is a medical technology company that develops a diagnostic method for mapping the spread of rectal cancer to lymph nodes. The company's patented technology combines a magnetic field, iron oxide-based nanoparticles, and ultrasound to provide high-resolution imaging and improve treatment planning for healthcare providers.
Clinical Laserthermia Systems develops minimally invasive laser ablation systems and thermal therapy products for use in oncology, urology, and neurosurgery. The company serves healthcare professionals and hospitals by providing tools for precise tissue ablation in treatments such as localized prostate cancer and brain lesions.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.